genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Oncolytic viruses
Cancer
ONCOTECH: A Chimeric Oncolytic Virus and T Cell for Cancer Immunotherapy
Cancer
Oncolytic Virus Improves Survival in Glioblastoma Trial
Cancer
Oncolytic Virus and Checkpoint Combo Shrinks Tumors
Genome Editing
How to Choose the Right Cell and Gene Therapy CDMO
Bioprocessing
Fighting Cancer with a Trojan Horse
Bioprocessing
IDT Biologika and Exothera Collaborate on Scaling Up Viral Vaccines
Cancer
Oncolytic Virus Activates Immune System against Colon Cancer
News
HSV-1 Genome Shown to Contain Significantly More ORFs
News
Interaction of Oncolytic Viruses Observed with Both Tumor and Healthy Cells
Cancer
Using Oncolytic Viruses to Boost Response to Immune Checkpoint Inhibitors
1
2
Page 1 of 2
Scroll Up
Scroll Up
